TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11744338

Group type: EXPERIMENTAL
Intervention: ADN plus glutamine 0.15 g x kg(‐1) x d(‐1)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: ADN plus glutamine 0.30 g x kg(‐1) x d(‐1)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Conventional casein‐based enteral formula (ADN)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: All groups combined (after enteral nutrition)
Number of subjects: 23
Study: 9419092

Group type: EXPERIMENTAL
Intervention: Microsurgical bipolar cautery tonsillectomy (TEmic)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional blunt dissection tonsillectomy (TEtrad)
Number of subjects: 200
Study: 8121965

Group type: EXPERIMENTAL
Intervention: Carbamazepine; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 3435906

Group type: EXPERIMENTAL
Intervention: Intracoronary SIN-1 (80 micrograms in 4 min)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2547030

Group type: EXPERIMENTAL
Intervention: MACC + W (methotrexate, doxorubicin, cyclophosphamide, and lomustine plus warfarin)
Number of subjects: 328

Group type: COMPARATOR
Intervention: MACC (methotrexate, doxorubicin, cyclophosphamide, and lomustine)
Number of subjects: 328

Group type: COMPARATOR
Intervention: MEPH/MACC (mitomycin, etoposide, cisplatin, and hexamethylmelamine alternating with MACC)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: MACC + W
Number of subjects: 328

Group type: COMPARATOR
Intervention: MACC
Number of subjects: 328

Group type: COMPARATOR
Intervention: MEPH/MACC
Number of subjects: 328
Study: 30784097

Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 to 150 mg BID
Number of subjects: 146
Study: 28973174

Group type: EXPERIMENTAL
Intervention: Low-dose alteplase (0.6 mg/kg; 15% as bolus and 85% as infusion over 1 hour)
Number of subjects: 3297

Group type: COMPARATOR
Intervention: Standard-dose alteplase (0.9 mg/kg; 10% as bolus and 90% as infusion over 1 hour)
Number of subjects: 3297

Group type: EXPERIMENTAL
Intervention: Low-dose alteplase
Number of subjects: 3297

Group type: COMPARATOR
Intervention: Standard-dose alteplase
Number of subjects: 3297
Study: 26169991

Group type: EXPERIMENTAL
Intervention: Intravenous TXA (15 mg/kg before tourniquet deflation)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intra-articular TXA (2 g via drain after wound closure)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 90
Study: 23948786

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg twice per day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 20827510

Group type: EXPERIMENTAL
Intervention: Phytoestrogens
Number of subjects: 1252
Study: 18803739

Group type: EXPERIMENTAL
Intervention: Collaborative practice model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (implied control)
Number of subjects: 0
Study: 16894334

Group type: EXPERIMENTAL
Intervention: Escitalopram (ESCIT) 10-20 mg/day (flexible dose) or 10 mg/day (fixed dose for the first 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Estrogen plus progestogen therapy (ethinyl estradiol 5 microg/day plus norethindrone acetate 1 mg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Escitalopram (ESCIT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Estrogen plus progestogen therapy (EPT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 15388905

Group type: EXPERIMENTAL
Intervention: Supplemental postoperative activity (arm and leg exercises, walking protocol)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard postoperative activity
Number of subjects: 58
Study: 11305883

Group type: EXPERIMENTAL
Intervention: Children in fundamentalist schools (5-7 years)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Children in nonfundamentalist schools (5-7 years)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Children aged 8-10 years
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Children's natural-history knowledge
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Children's religious interest
Number of subjects: 277
Study: 9140675

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nitrendipine 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7950558

Group type: EXPERIMENTAL
Intervention: Reduction in absolute risk reported
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Number needed to treat reported
Number of subjects: 802

Group type: COMPARATOR
Intervention: Reduction in relative risk reported
Number of subjects: 802
Study: 3675696

Group type: EXPERIMENTAL
Intervention: Amoxicillin 1500 mg/d + Ambroxol 90 mg/d (n = 10)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Amoxicillin 1500 mg/d (n = 13)
Number of subjects: 23
Study: 29235242

Group type: EXPERIMENTAL
Intervention: Educational intervention for rheumatoid arthritis with clinical simulation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Educational intervention for the basic aspects of the diagnosis and treatment of osteoporosis
Number of subjects: 160
Study: 27432166

Group type: EXPERIMENTAL
Intervention: Metformin (1 g) with lifestyle recommendations
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo with lifestyle recommendations
Number of subjects: 160
Study: 25022428

Group type: EXPERIMENTAL
Intervention: Individual intervention (IG)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: One‐meeting discussion group (DG)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Activity group (AG)
Number of subjects: 177
Study: 22374987

Group type: EXPERIMENTAL
Intervention: ABC/3TC
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: TDF/FTC
Number of subjects: 56
Study: 20335626

Group type: EXPERIMENTAL
Intervention: Low-phytate maize
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: 5-mg zinc supplement
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Combination of low-phytate maize and zinc supplement
Number of subjects: 412

Group type: COMPARATOR
Intervention: Control maize
Number of subjects: 412

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 412
Study: 18387700

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 71

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 71
Study: 15713944

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily
Number of subjects: 2035

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg twice daily
Number of subjects: 2035

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2035
Study: 12538431

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 15,000 to 30,000 IU per week for 3 months
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 26
Study: 11761012

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: No omeprazole treatment
Number of subjects: 18
Study: 9250109

Group type: EXPERIMENTAL
Intervention: 25 mg beta-carotene/d for 4 years
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 8214666

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg MCA
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg MCA
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg MCA
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: DPD (0.01 and 0.02 mg/kg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control
Number of subjects: 96
Study: 3423731

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31540384

Group type: EXPERIMENTAL
Intervention: Red wine (RW)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indian pale ale beer (IPA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Blonde beer
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Non-alcoholic beer (free)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All beers
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Polygenic activity score (PAS)
Number of subjects: 20
Study: 28974071

Group type: EXPERIMENTAL
Intervention: Sleep-deprived group (SLD, n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rested group (R, n=10)
Number of subjects: 20
Study: 25510857

Group type: EXPERIMENTAL
Intervention: L-dopa (50 mg levodopa and 12.5 mg carbidopa)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23663556

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention for depression
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 36
Study: 20409050

Group type: EXPERIMENTAL
Intervention: Musical distraction with headphones
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Musical distraction without headphones
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 118
Study: 19006463

Group type: EXPERIMENTAL
Intervention: Internet-based therapy (IBT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Waiting list (WL)
Number of subjects: 62
Study: 17585666

Group type: EXPERIMENTAL
Intervention: Red-hot needle therapy combined with blood-letting puncture and cupping
Number of subjects: 96

Group type: COMPARATOR
Intervention: Halometasone cream (control)
Number of subjects: 96
Study: 15082482

Group type: EXPERIMENTAL
Intervention: Intermittent pulse cyclophosphamide plus methylprednisolone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Continuous cyclophosphamide plus azathioprine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 11152840

Group type: EXPERIMENTAL
Intervention: Relative risk reduction
Number of subjects: 400

Group type: COMPARATOR
Intervention: Absolute risk reduction
Number of subjects: 400

Group type: COMPARATOR
Intervention: Number of patients needed to be treated to prevent 1 death
Number of subjects: 400

Group type: COMPARATOR
Intervention: Increased life expectancy (distractor)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Decreased hospitalization rate (distractor)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Decreased cost (distractor)
Number of subjects: 400
Study: 9479674

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Active Listening (AL)
Number of subjects: 60
Study: 7809761

Group type: EXPERIMENTAL
Intervention: Chemonucleolysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous nucleotomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative therapy (bed rest, information, analgesics)
Number of subjects: 0
Study: 3056084

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (100 mg continuous infusion in 5% glucose over 10 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (5% glucose)
Number of subjects: 20
Study: 31246283

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks until further progression)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Nivolumab (TBP group)
Number of subjects: 62
Study: 28320187

Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 13
Study: 26468007

Group type: EXPERIMENTAL
Intervention: Capecitabine plus cisplatin (CC)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Capecitabine plus paclitaxel (CP)
Number of subjects: 94
Study: 23278145

Group type: EXPERIMENTAL
Intervention: Triple-headed toothbrush
Number of subjects: 43

Group type: COMPARATOR
Intervention: Single-headed toothbrush
Number of subjects: 43
Study: 21854199

Group type: EXPERIMENTAL
Intervention: Lavender oil aromatherapy (oxygen with a face mask coated with lavender oil for 5 minutes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (oxygen through a face mask with no lavender oil for 5 minutes)
Number of subjects: 30
Study: 19698089

Group type: EXPERIMENTAL
Intervention: bilateral continuous theta burst stimulation (cTBS) applied to the secondary auditory cortex
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: bilateral continuous theta burst stimulation (cTBS) applied to the temporoparietal association cortex
Number of subjects: 48

Group type: COMPARATOR
Intervention: sham condition (lower occiput)
Number of subjects: 48
Study: 16426274

Group type: EXPERIMENTAL
Intervention: Chronic daily headache (CDH)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Episodic headache (EH)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Drug addicts (DA)
Number of subjects: 308
Study: 15533865

Group type: EXPERIMENTAL
Intervention: Avasimibe 50 mg QD
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Avasimibe 250 mg QD
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Avasimibe 750 mg QD
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 11375853

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Combination of GA and intraoperative thoracic epidural analgesia (TEA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Multimodal approach (intraoperative GA and TEA, postoperative patient‐controlled TEA, early oral nutrition, enforced mobilization)
Number of subjects: 45
Study: 9466279

Group type: EXPERIMENTAL
Intervention: Prednisone (60 mg p.o. twice a day followed by a 2-month taper)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Non-invasive clinical scoring system
Number of subjects: 64
Study: 8543105

Group type: EXPERIMENTAL
Intervention: Routine obstetric ultrasound
Number of subjects: 0
Study: 2332565

Group type: EXPERIMENTAL
Intervention: Inhaled furosemide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 467943

Group type: EXPERIMENTAL
Intervention: sulfasalazine
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: prednisone or azathioprine
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: ileocolitis
Number of subjects: 569

Group type: COMPARATOR
Intervention: small bowel disease
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: colitis or ileocolitis
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: perianal disease
Number of subjects: 569
Study: 31091717

Group type: EXPERIMENTAL
Intervention: Non-core foods
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Core foods
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Non-core food snacking
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Core food snacking
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mixed meals
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Purchased products
Number of subjects: 36
Study: 27203271

Group type: EXPERIMENTAL
Intervention: Heart cluster (chest pain/discomfort and palpitations/fluttering)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Vagal cluster (nausea and diaphoresis)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Tired cluster (fatigue/lethargy, weakness, syncope/dizziness, and dyspnea/breathlessness)
Number of subjects: 335
Study: 25855155

Group type: EXPERIMENTAL
Intervention: Ceralifimod 0.10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ceralifimod (0.05 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fingolimod (0.5 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ceralifimod
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 24965190

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 80
Study: 22776351

Group type: EXPERIMENTAL
Intervention: Severely obese children
Number of subjects: 100
Study: 20389096

Group type: EXPERIMENTAL
Intervention: Highly purified hMG (Menopur)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Recombinant FSH (Gonal‐F)
Number of subjects: 5
Study: 17699990

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 60
Study: 16159816

Group type: EXPERIMENTAL
Intervention: SICTRA with MV surgery (group A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: MV surgery alone (group B)
Number of subjects: 70
Study: 12105160

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) 10 mg/24 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) with ascorbate (2.4 g/24 hours)
Number of subjects: 0
Study: 10022633

Group type: EXPERIMENTAL
Intervention: Long-term NSAID therapy (Group I)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: No NSAID therapy (Group II)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Healthy volunteers (Group III)
Number of subjects: 95
Study: 8815569

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) certoparin (3,000 IU) combined with dihydroergotamine (DHE) (0.5 mg) subcutaneously once daily
Number of subjects: 305

Group type: COMPARATOR
Intervention: Adjusted-dose unfractionated heparin (UFH) subcutaneously every 8 hours
Number of subjects: 305
Study: 1381636

Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 660

Group type: COMPARATOR
Intervention: Cephamandole
Number of subjects: 660
Study: 6339343

Group type: EXPERIMENTAL
Intervention: Spironolactone and 500 mg Na p.d
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Spironolactone + furosemide or Moduretic and 500 mg Na p.d
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Spironolactone + Furosemide or Moduretic and unrestricted sodium diet
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Concentrated ascites reinfusion and 500 mg Na p.d
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Unmodified ascites reinfusion and 500 mg Na p.d
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Slow ascites drainage and 500 mg Na p.d
Number of subjects: 328
Study: 31450257

Group type: EXPERIMENTAL
Intervention: Solution-Focused Group Counseling (SFGC) for 5 sessions of 75 minutes each
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Solution-Focused Group Counseling (SFGC)
Number of subjects: 40
Study: 28329121

Group type: EXPERIMENTAL
Intervention: Ex/HE
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Ex/Diet
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Ex/VLCD
Number of subjects: 117
Study: 26218729

Group type: EXPERIMENTAL
Intervention: rimabotulinumtoxinB (1,500 U)
Number of subjects: 24

Group type: COMPARATOR
Intervention: onabotulinumtoxinA (50 U)
Number of subjects: 24
Study: 23704830

Group type: EXPERIMENTAL
Intervention: Danzhijiangtang capsule (DJC)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (routine western medicine)
Number of subjects: 62
Study: 21422407

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 4325

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 4325

Group type: EXPERIMENTAL
Intervention: Both treatments (Exemestane and Tamoxifen)
Number of subjects: 4325

Group type: EXPERIMENTAL
Intervention: Quantitative analysis of ER and PgR expression
Number of subjects: 4325
Study: 19137351

Group type: EXPERIMENTAL
Intervention: Hip protectors
Number of subjects: 672

Group type: COMPARATOR
Intervention: Control group (no hip protectors)
Number of subjects: 672
Study: 17199134

Group type: EXPERIMENTAL
Intervention: Bicalutamide 80 mg + LHRH-A
Number of subjects: 205

Group type: COMPARATOR
Intervention: LHRH-A
Number of subjects: 205
Study: 15003438

Group type: COMPARATOR
Intervention: Placebo (2 g liquid paraffin per day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) (2 g per day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: EPA
Number of subjects: 11
Study: 11307178

Group type: EXPERIMENTAL
Intervention: High doses of antioxidants
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 46
Study: 1307880

Group type: EXPERIMENTAL
Intervention: Three-wavelength continuous SvO2 catheter
Number of subjects: 60

Group type: COMPARATOR
Intervention: Two-wavelength continuous SvO2 catheter
Number of subjects: 60
Study: 3986067

Group type: EXPERIMENTAL
Intervention: Extradural local anaesthetics (0.5% bupivacaine)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Extradural morphine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (morphine i.v.)
Number of subjects: 3
Study: 29427365

Group type: EXPERIMENTAL
Intervention: Negative self-focused thought (negative-SFT)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Depression group
Number of subjects: 79
Study: 27090364

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with Dermatophagoides pteronyssinus (D.pt) extract
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (drugs only)
Number of subjects: 61
Study: 24173029

Group type: EXPERIMENTAL
Intervention: HiP-AS (with AS03 adjuvant)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HiP (without AS03 adjuvant)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Engerix B (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HiP-AS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HiP
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HiP-AS and HiP
Number of subjects: 40
Study: 22933427

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (E+P)
Number of subjects: 2535

Group type: COMPARATOR
Intervention: Estrogen alone (E‐alone)
Number of subjects: 2535

Group type: EXPERIMENTAL
Intervention: Active treatment (E+P or E‐alone)
Number of subjects: 2535

Group type: EXPERIMENTAL
Intervention: Baseline levels of 2‐OHE1 and the 2:16 ratio
Number of subjects: 2535

Group type: EXPERIMENTAL
Intervention: Baseline levels of 16α‐OHE1
Number of subjects: 2535
Study: 20530393

Group type: EXPERIMENTAL
Intervention: Facilitated intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Self-directed intervention
Number of subjects: 36
Study: 19020132

Group type: EXPERIMENTAL
Intervention: Sevoflurane (group S)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sevoflurane and dexmedetomidine (group SD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol and dexmedetomidine (group PD)
Number of subjects: 60